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Abstract
Atopic eczema (AE) is associated with Staphylococcus aureus (S. aureus) colonization and
skin barrier dysfunction, often measured by increased transepidermal water loss (TEWL). In
the present study, the primary aim was to see whether S. aureus colonization in the vestibu-
lum nasi and/or fauces was associated with increased TEWL in infants with healthy skin
and infants with eczema. Secondarily, we aimed to investigate whether TEWLmeasure-
ments on non-lesional skin on the lateral upper arm is equivalent to volar forearm in infants.
In 167 of 240 infants, recruited from the general population, TEWL measurements on the
lateral upper arm and volar forearm, using a DermaLab USB, fulfilled our environmental re-
quirements. The mean of three TEWL measurements from each site was used for analysis.
The infants were diagnosed with no eczema (n = 110), possible AE (n = 28) or AE (n = 29).
DNA samples were analysed for mutations in the filaggrin gene (FLG). Bacterial cultures
were reported positive with the identification of at least one culture with S. aureus from vesti-
bulum nasi and/or fauces. S. aureus colonization, found in 89 infants (53%), was not associ-
ated with increased TEWL (i.e. TEWL in the upper quartile), neither on the lateral upper arm
or volar forearm (p = 0.08 and p = 0.98, respectively), nor with AE (p = 0.10) or FLGmutation
(p = 0.17). TEWL was significantly higher on both measuring sites in infants with AE com-
pared to infants with possible AE and no eczema. FLGmutation was significantly associat-
ed with increased TEWL, with a 47% difference in TEWL. We conclude that S. aureus in
vestibulum nasi and/or fauces was not associated with TEWL, whereas TEWL measure-
ments on the lateral upper arm and volar forearm appear equally appropriate in infants.
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Introduction
Atopic eczema (AE) is a common skin disease and is characterized by dry skin, pruritus, and
eczematous skin [1,2]. In infants with AE, the eczema is frequently located in the face and/or
scalp. In older children, the eczema more often has a flexural distribution, although lateral part
of the upper arms may also be involved [3–7]. The onset of AE is usually early in life, with a
majority being reported before the age of 12 months [1].
The pathogenesis of AE is complex, involving skin barrier dysfunction, immune dysregula-
tion, cutaneous inflammation and colonization with Staphylococcus aureus (S. aureus) [1,8–
10]. Dysfunction of the skin barrier leads to increased water loss and increased entry of
allergens, toxins, and infectious microorganisms [1]. Skin barrier function can be evaluated by
measuring transepidermal water loss (TEWL) [11]. Increased TEWL, indicating a skin barrier
dysfunction, is often found in patients with AE [12,13], but has also been reported in infants
with dry skin and mutation in the gene encoding for the profilaggrin protein [14]. Filaggrin de-
ficiency is a major predisposing factor for AE [15] and may also be an independent increased
risk factor for S. aureus colonization [16].
Increased TEWL has been found to be associated with S. aureus colonization on clinically
normal skin in adults [17]. In infants, the S. aureus colonization rate in healthy skin is low [18].
S. aureus is thought to act as a superantigen contributing to the development of AE [19]. Pa-
tients with AE, regardless of age, are frequently colonized by S. aureus [1,19–24], and the num-
ber of colonization sites, has been associated with the severity of AE [12,23,25] The vestibulum
nasi could be a reservoir of S. aureus, with the bacteria spreading to the skin by autotransmis-
sion [20,25–27]. Also, nasal colonization of S. aureus at six months of age has been reported to
be associated with an increased risk of AE in the 2nd year of life [28]. In a study on patients
and staff at an orthopedic ward in Sweden, S. aureus colonization was more frequent in the
throat than in anterior nares [29].
TEWL may vary by anatomical site [11,30–32]. TEWL is most often measured on the volar
forearm [30]. In infants, however, AE in infancy is often located on the lateral part of upper
arm [6,7], suggesting that the skin barrier may better reflect possible disease association at this
loctation rather than at the volar forearm that is more often free of eczema manifestation in in-
fants. Standard temperature and humidity conditions as well as a calm baby are vital for mea-
surements of TEWL. Thus, easy access to the lateral upper arm, reducing the risk of excess heat
or humidity by the infant flexing the lower arm, and a location more often associated with
atopic eczema manifestation renders the lateral upper arm as a suitable site for TEWL mea-
surements in infants. We are not aware of studies comparing TEWL on volar forearm and
TEWL on lateral upper arm in infants.
The main objective of the present study was to investigate if S. aureus colonization in vesti-
bulum nasi and/or fauces, potentially preceding AE, is associated with skin barrier dysfunction
as assessed by TEWL measurements in infants recruited from a general population. The sec-
ondary aims were to investigate if TEWL measurements on the lateral upper arm and volar
forearm provide similar associations between TEWL and AE and to assess correlations between
four common FLGmutations and S. aureus colonization and TEWL measurements.
Materials and Methods
The present study included infants from a general population, serving as a control population
of the Bronchiolitis All SE-Norway study [33], registered at ClincialTrials.gov number
NCT00817466, EudraCT number, 2009-012667-34. A letter of invitation was sent to the pa-
rents of 2,400 infants, randomly selected from the general population register of Oslo and Fre-
drikstad, two cities in the south east of Norway. Of these, 240 responded and were enrolled.
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The inclusion criterion was age 12 months or younger at the time of recruitment. Exclusion cri-
teria were any cardiac, pulmonary (other than obstructive airways disease), immunological,
neurological or oncological disease assumed to affect an infant’s eczema.
The infants were examined within three months fromMarch 2012. One or both parents
were interviewed using a structured questionnaire that included questions on previous and cur-
rent health and diseases of the child and family members, socio-economic status, quality of life
and environmental exposures.
The study was approved by the Regional Committee for Medical and Health Research Eth-
ics, the biobank was registered appropriately, and informed written consent was obtained from
all caregivers.
Subjects
Of the 240 enrolled infants, this study includes the 167 infants (mean age 6.4 months) whose
TEWL measurements fulfilled our requirements for temperature and humidity (Table 1). Sub-
jects were excluded due to crying (n = 7) or non-optimal measuring conditions, i.e. humidity
(n = 66) and/or temperature (n = 35).
Experienced and trained physicians performed the clinical examinations at one visit. All
skin assessments were performed strictly by validated scoring criteria in collaboration with a
dermatologist. AE was diagnosed according to the criteria of Hanifin & Rajka, requiring the
presence of minimum three of four major criteria and minimum three of 23 minor criteria [5].
Infants with clinical eczema, but not meeting these criteria, were classified as having possible
AE. The SCORing Atopic Dermatitis index (SCORAD index) was used to score disease severity
in those with AE [34]. Reported SCORAD is the mean of the score by the primary investigator
(physician) and the secondary investigator (physician or trained study nurse).
TEWLmeaurements
TEWL was measured on non-lesional skin on the lateral part of upper arm and volar forearm,
using the open chamber DermaLab USB (Cortex, Hadsund, Denmark) system. The infants
were first acclimatized to the examination room for at least 15 minutes, wearing a diaper only.
Investigations were performed while attempting a room temperature of 20–22°C and humidity
of 40% [30]. Using different examination rooms, it was not possible to maintain these air hu-
midity and temperature requirements in a strict manner. We accepted measurements per-
formed at temperature 20–25°C, in line with a study of Kelleher et al [35], and humidity from
20 to 50%. Measurements were disregarded if the infants were crying. TEWL values were re-
ported as the mean of three measurements performed for each test site.
Bacterial cultures
Samples for bacterial cultures, using ESwab (Copan, Brescia, Italia), were taken from both the
vestibulum nasi and fauces and cultivated on a blood agar plate as well as a selective plate for S.
aureus (mannitol-salt agar) for two days. Growth of S. aureus was identified by a rapid aggluti-
nation test (Pastorex Staph Plus, Alere, UK) and registered semi-quantitatively. Samples from
vestibulum nasi and/or fauces in one subject were reported as positive with at least one culture
with S. aureus being identified. In infants with AE, bacterial cultures were also taken from
eczematous skin.
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Genotyping
Blood samples were drawn from all infants using standard procedure. DNA was isolated from
peripheral whole blood using QIAsymphony DNAMidi KIT (QIAGEN Instruments AG, Swit-
zerland). All samples were screened for the four most common FLGmutations in the European
population, i.e. R501X, 2282del4, R2447X and S3247X, using TaqMan allelic discrimination
assays with minor modifications [36,37]. Two DNA plates (for a maximum of 174 samples)
were genotyped twice for each mutation. The genotyping concordance was 100% when com-
paring samples that received a genotype call in both runs.The genotyping success rate for
R501X, 2282del4, R2447X, S3247X and combined null was 99.7, 99.3, 97.9, 96.0, and 93.4%,
respectively.
Statistical analysis
Data are presented as percentages, except for continuous data, which are presented as estimat-
ed means with 95% confidence intervals (CI), unless otherwise stated. As TEWL values were
not normally distributed, comparisons between groups were performed by robust regression
analyses [38]. Comparison of infants with no eczema, possible AE and AE with regard to
S. aureus colonization was performed by Chi square tests or robust one-way ANOVA, as
appropriate.
As the cohort was established to serve as a control cohort for another study [33], a post-hoc
power analysis was performed for S. aureus colonization and TEWL. Comparing group sizes of
129, 34 and 35 of three groups with mean TEWL values of 7.9, 8.4 and 10.8 g/m2h-1 would
achieve 82% power to detect significant differences using a standard deviation of 9.7.
Due to difficulties in obtaining required measurement conditions, post-hoc analyses of the
potential impact of temperature and humidity on TEWL measurements were performed, using
Table 1. Characteristics.
Included infants n = 167 Excluded infants n = 73 p-values
Male 87 (52) 47 (64) 0.08
Age (months; min-max) 6.4 (1.1–13.4) 6.9 (1–13.6) 0.26
No eczema 110 (66) 49 (67) 0.63
Possible atopic eczema 28 (17) 9 (12) 0.63
Atopic eczema 29 (17) 15 (21) 0.63
Mother Caucasian 156 (93) 70 (96) 0.58
Father Caucasian 152 (92) 68 (93) 0.58
Smoking at home 5 (3) 5 (7) 0.18
Cat at home 18 (11) 10 (14) 0.56
Dog at home 14 (9) 11 (16) 0.11
Parental eczema 62 (37) 15 (21) 0.01
Parental asthma 45 (27) 20 (27) 0.94
Parental rhinitis 92 (55) 40 (55) 0.97
Filaggrin mutation 14 (8) 2 (3) 0.11
S. aureus vestibulum nasi 47 (28) 13 (18) 0.09
S. aureus fauces 73 (44) 28 (38) 0.43
S. aureus vestibulum nasi/fauces 89 (53) 33 (45) 0.25
Characteristics of 240 infants, recruited from the general population in Oslo and Fredrikstad, Norway, of whom 167 were included and 73 excluded from
the analyses. Exclusions were done due to crying during the measuring transepidermal water loss (n = 7) and/or measuring conditions not fulﬁlling strict
environmental criteria for humidity and/or temperature (n = 66). All values are given as number (percentage), unless otherwise stated.
doi:10.1371/journal.pone.0130145.t001
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Spearman correlation coefficient. These analyses revealed weak associations with temperature
(r = 0.16; p = 0.002), but not with humidity (r = 0.052; p = 0.48). We therefore repeated the
analyses including all 198 infants with TEWL measurements performed under the chosen tem-
perature criteria, with results given in the online supplements (S1 and S2 Tables).
The level of statistical significance was set to 0.05. Statistical analysis was performed using
IBM Statistical Package for Social Sciences (IBM SPSS Statistics, Version 21.0.1. Armonk, NY:
IBM Corp) version 21.0 and Number Cruncher Statistical System (NCSS Inc., Kaysville, Utah),
version 9.09.
Results
The 167 infants included in the analyses were similar to the 73 excluded infants with respect to
demographic and clinical parameters, except for more frequent parental eczema among the in-
cluded infants (Table 1). Of the 167 included infants, 110 (66%) had no eczema, 28 (17%) pos-
sible AE and 29 (17%) AE. In infants with AE, the median SCORAD was 16.5 (range 7.5, 39.0).
The mean TEWL levels were significantly higher in infants with AE than in those with pos-
sible AE and with no eczema on both measurement sites (lateral upper arm p<0.001 and volar
forearm p = 0.02, respectively) (Table 2). In infants with no eczema, the mean TEWL was 7.7
g/m2h-1 (95% CI 7.1, 8.4) on the lateral upper arm and 9.3 (8.4,10.2) on the volar forearm
(p<0.001), with no significant differences in TEWL between the two measuring sites in those
with possible AE and AE.
S. aureus colonization was observed in 89 infants (53%), i.e. 73 infants (44%) with coloniza-
tion in the fauces and 47 (28%) with colonization in vestibulum nasi; 31 infants (19%) were col-
onized in both fauces and vestibulum nasi. The S. aureus colonization rates in vestibulum nasi
and fauces were non-significantly higher in infants with AE compared to infants with possible
AE and no eczema (vestibulum nasi 41, 30, 25%, respectively; p = 0.20; and fauces 55, 48, 40%,
respectively; p = 0.30). The S. aureus colonization rate in the vestibulum nasi and fauces com-
bined was non-significantly higher in infants with AE (69%) compared to infants with possible
AE (57%) and no eczema (48%) (p = 0.12). Of the 29 infants with AE, eight were colonized
with S. aureus on eczematous skin; all of these were colonized in the fauces and five in vestibu-
lum nasi.
There was no significant association between S. aureus colonization in vestibulum nasi and/
or fauces and high TEWL (i.e. upper quartile) on lateral upper arm, as well as on volar forearm
(p = 0.08 and p = 0.98, respectively), both among all infants (Fig 1) and after stratification for
no eczema, possible AE and AE (all p>0.1). In infants with no eczema, the S. aureus coloniza-
tion rate was 59% in infants with high TEWL (i.e. upper quartile) on the lateral upper arm and
48% in infants with low TEWL (i.e. lower quartile) (p = 0.41). In infants with AE, there was no
significant association between S. aureus colonization rates in vestibulum nasi and/or fauces or
eczematous skin and TEWL.
Loss of function mutations in the FLG gene, i.e. R501X, 2282del4, R2447X and S3247X,
identified in 14 infants (8%), all heterozygous, was associated with increased TEWL both on
the lateral upper arm and volar forearm (p = 0.006 and p = 0.03, respectively) (Fig 2). The FLG
mutation was not significantly associated with S. aureus colonization in any of the groups with
respect to no eczema, possible or AE, or with disease severity in those with AE (all p>0.1).
Results regarding S. aureus colonization and TEWL remained largely unchanged when in-
fants with TEWL measurements not fulfilling strict humidity requirements were included in
the analysis, enlarging the cohort to 198 infants (S1 Text, S1 and S2 Tables). Also, when includ-
ing all enrolled infants, resulting in a cohort of 240 infants, the association between S. aureus
colonization and AE remained largely unchanged.
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Discussion
In the present study, S. aureus colonization in vestibulum nasi and/or fauces, observed in 53%
of infants recruited from the general population, was not significantly associated with increased
TEWL, nor with AE or FLGmutation. Measurements of TEWL appeared to be equally appro-
priate on the lateral upper arm as on the volar forearm.
The relatively high rate of S. aureus colonization in the vestibulum nasi and/or fauces in our
cohort was in line with a Danish population based cohort study reporting a nasal colonization
of 51.3% in 2–11 week age infants [39], but was higher than the nasal colonization of 21.1% de-
scribed in a Dutch prospective birth cohort study at six months age [28]. In the present study,
we combined the colonization rates of vestibulum nasi and fauces, as the fauces may be a major
carriage site of S. aureus in addition to vestibulum nasi [29]. In the Danish study, infants were
recruited among infants whose mothers had asthma, of whom about half also had AE [39]. The
Dutch study was a prospective cohort study from fetal life until young adulthood, with a ran-
domly selected cohort with a low prevalence of parental eczema [28]. Our cohort was recruited
from the general population, although with some unintentional bias towards including more
infants of parents with eczema. These differences may explain the different rates of S. aureus
colonization in the three studies.
In the present study, eight infants with AE and S. aureus colonization on eczematous skin
were also colonized in the vestibulum and/or fauces. Although the numbers are small, this is in
line with studies where eczematous skin in patients with AE were colonized with the same bac-
terial strain as in the vestibulum nasi and/or fauces [25,26]. The nostrils is a source for S. aureus
skin colonization [25,27]. These findings could be explained by autotransmission of S. aureus.
In the present study, S. aureus colonization rates in vestibulum nasi and/or fauces was non-
significantly higher in infants with AE than in those with possible AE and no eczema. Several
factors may contribute to S. aureus colonization in infants with AE, including immunological
responses [40,41]. In AE, there is a Th2 response with increased levels of cytokines, contribut-
ing to the susceptibility to S. aureus in AE [41–43].
The lack of association between TEWL and S. aureus colonization in vestibulum nasi and/
or fauces in infants with no eczema, possible AE and AE has to our knowledge not been re-
ported previously. Others have reported an association between S. aureus colonization on the
cheek and forehead and increased TEWL in healthy adults with normal skin [17]. Also, in a
Swedish study of adult patients with AE, S. aureus skin colonization was significantly associat-
ed with TEWL on eczematous skin [12]. In Korean AE patients aged 1–40 years old, S. aureus
colonization in anterior nares was reported to be non-significantly correlated with high TEWL
[25]. The apparent discrepancies between these studies may have several explanations. First,
age may modify the results, as adults generally have lower TEWL than infants [44]. Also, sam-
pling sites and circumstances were different. In our study, S. aureus was detected in vestibulum
Table 2. Transepidermal water loss (TEWL).
No eczema n = 110 Possible AE n = 28 AE n = 29 Overall p-value
Lateral upper arm 7.7 (7.1,8.4) 8.5 (7.2,9.8) 11.0a (9.7,12.4) 0.0002
Volar forearm 9.3 (8.4,10.2) 9.2 (7.4,10.9) 12.8a (11.1,14.6) 0.02
Transepidermal water loss (TEWL) in 167 infants, recruited from the general population in Oslo and Fredrikstad, Norway, with no eczema, possible atopic
eczema (AE) and AE. Measurements were performed three times and recorded as mean g/m2h-1 each site. Results are given as estimated mean (95%
CI) from robust regression analysis.
ap<0.001 AE vs. possible AE. There was no signiﬁcant difference between possible AE and no eczema.
doi:10.1371/journal.pone.0130145.t002
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nasi and fauces and TEWL measured on the lateral upper arm and volar forearm in infants
with and without eczema, in contrast to the other studies, where S. aureus was detected on nor-
mal and eczematous skin, respectively. Although an association between S. aureus colonization
in vestibulum nasi and/or fauces and TEWL in infants cannot be ruled out, the present study
had a sufficient statistical power to detect significant differences of 82%. Our findings do not
support a hypothesis that increased susceptibility to S. aureus in the vestibulum nasi and/or
fauces is associated with increased TEWL and precedes the development of AE.
Fig 1. Staphylococcus aureus colonization and transepidermal waterloss. Boxplot showing Staphylococcus aureus (S. aureus) colonization in
vestibulum nasi and/or fauces in 89 (53%) of 167 infants recruited from the general population was not significantly associated with the estimated mean
transepidermal waterloss (TEWL; g/m2h-1) on the lateral upper arm.
doi:10.1371/journal.pone.0130145.g001
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TEWL measurements on the lateral upper arm differentiated well between no, possible AE
and AE, and appeared to be at least as good, or possibly better, than measurements performed
at the standard site of the volar forearm. We are not aware of other studies using this site for
TEWL measurements in infants. In line with other studies, TEWL was increased in infants
with AE compared to infants with possible AE and no eczema for both measuring sites [13].
Having a FLGmutation was associated with high TEWL, but did not modify the results. These
findings may have several implications. Cohort studies assessing pre-morbid skin barrier
Fig 2. Transepidermal waterloss and filaggrinmutation. Boxplot showing filaggrin (FLG) mutation identified in 14 (8%) of 167 infants recruited from the
general population and transepidermal water loss (TEWL; g/m2h-1) on the lateral upper arm. FLGmutations were associated with increased TEWL
(p = 0.006).
doi:10.1371/journal.pone.0130145.g002
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function for potential disease prediction would benefit from using standard sites that are com-
monly associated with development of AE, i.e. the lateral upper arm [6,7]. Also, the lateral
upper arm is easily accessible during nursing of infants, improving the feasibility of measure-
ments in a relaxed and content infant. Our study therefore indicates that TEWL measurements
on lateral upper arm may be as appropriate for the evaluation of skin barrier function in infants
as TEWL measurements on volar forearm.
TEWL measurements were performed using an open chamber system, enabling consecutive
measurements [45]. The observed mean TEWL in our infants without eczema were slightly
higher than, but generally in line with those observed in a cohort study with more than 1,000
new-born infants in Ireland, examined shortly after birth and using another open chamber sys-
tem [35]. Open chamber devices require an environment without air turbulence, in contrast to
the closed chamber systems, either an unventilated chamber or a condensed chamber system.
Unventilated chamber systems compare ambient humidity with the humidity within the
chamber after a filling time, but require some time to evaporate before starting the next mea-
surement. Condensed chamber systems measure water vapor flux density and can make conse-
cutive measurements. In vitro comparisons have shown a good correlation between various
open chamber systems and condensed chamber systems with titrated water flux [45]. Open
chamber systems appear more sensitive to changes in TEWL in the lower range [46]. Thus, all
three measuring systems appear valid in research, but results should not be directly compared
[45].
All infants were acclimatized to the ambient environment for at least 15 minutes, in line
with present guidelines [30]. Even though great care was taken to achieve strict and stable con-
ditions, it was not possible to meet the temperature and air humidity criteria for all infants,
with the subsequent exclusion of many infants from the main analysis. The temperature was
slightly higher than recommended in the guidelines, but similar to the temperature in the
study by Kelleher et al [35]. The importance of air humidity in TEWL measurements has re-
sulted in recommendations of relative air humidity to approximately 40% [30]. However, re-
sults from studies on the impact of humidity on TEWL are somewhat conflicting [47,48]. We
therefore retrospectively evaluated the potential impact of humidity and temperature on
TEWL measurements, finding that humidity was not significantly associated with the TEWL
measurements, whereas temperature was slightly associated (on line supplement only). The
largely unchanged results of our repeated analyses including infants whose TEWL measure-
ments had been performed under strict temperature criteria (20–25°C, mean 23.7°C), but al-
lowing for indoor relative humidity levels between 14 and 64% (mean 31.7%), may question
the present recommendations regarding indoor humidity. In our opinion, these requirements
should be balanced against the feasibility of measuring TEWL in infants.
Conclusion
In the present study with infants recruited from a general population, S. aureus colonization in
vestibulum nasi and/or fauces was not associated with TEWL measured on the arm, or with
atopic eczema. Measuring TEWL on the lateral upper arm appears to be appropriate for the
evaluation of skin barrier function in infants.
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